Navigation Links
LCA-Vision to Present at the Noble Financial Eighth Annual Equity Conference
Date:1/12/2012

CINCINNATI, Jan. 12, 2012 /PRNewswire/ -- LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today announced that management will present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012, at 3:00 p.m. Eastern time.  A live and archived webcast of the presentation will be available at the Investor Relations section of LCA-Vision's website at www.lasikplus.com.
The conference is being held at the Hard Rock Hotel in Hollywood, Fla.

About LCA-Vision Inc./LasikPlus®
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, operates 53 LasikPlus® fixed-site laser vision correction centers in 26 states and 41 markets in the United States.  Additional company information is available at www.lca-vision.com and www.lasikplus.com.

Earning Trust Every Moment; Transforming Lives Every Day.For Additional InformationCompany Contact:Investor Relations Contact:Barb Kise

Jody CainLCA-Vision Inc.

LHA513-792-9292

310-691-7100


'/>"/>

SOURCE LCA-Vision Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. LCA-Vision Announces CEO Resignation
2. LCA-Vision Names Michael J. Celebrezze CFO
3. PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012
4. Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference
5. NW Bio to Present Today at the OneMedForum SF 2012 Conference
6. Chembio Presenting at Biotech Conference
7. 3SBio Inc. to Present at the UBS Greater China Conference 2012
8. PAREXEL International to Present at J.P. Morgan Healthcare Conference
9. Reata Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
10. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
11. InterMune to Present at J. P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 For today, ... on novel drug development and clinical research aimed at treating ... Inc. (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma ... ZIOP ). You can access our complimentary research reports on ... ...
(Date:4/19/2017)... ... April 18, 2017 , ... Alisa Wright, founder and CEO of ... the Purdue College of Pharmacy in Lafayette, Indiana. , The Distinguished Alumni Award ... in their careers and other scientific endeavors. , Wright began her career in ...
(Date:4/19/2017)... ... April 19, 2017 , ... ThermaGenix, the ... This event adds to several other early achievements at ThermaGenix, including the business ... , ThermaGenix will use proceeds from the Series A-1 round to:, ...
(Date:4/19/2017)... PUNE, India , April 19, 2017 ... Global Opportunity Analysis and Industry Forecast, 2014-2022 ," the global market was valued ... 2022, registering a CAGR of 9.6% from 2016 to 2022. ... ...      ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
Breaking Biology News(10 mins):